Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer
Pathology - Research and Practice · 2026-04 · 280 · 156398
DOI: 10.1016/j.prp.2026.156398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-04. Verfasst von Afsheen Raza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Health Sciences, Abu Dhabi University, United Arab Emirates; Cancer Research Institute, Office of Resea…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Ovarian Neoplasms, Cell Plasticity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 194 Literaturangaben. Gefördert von: Abu Dhabi University.
Abstract (Originalsprache)
Epithelial-mesenchymal transition (EMT) is essentially a way for epithelial cells to loosen their structure and take on a more mobile, survival-driven identity. In ovarian cancer, this shift may be one of the reasons the disease spreads so readily and comes back despite intensive treatment. A mix of transcription factors Snail, Slug, Twist, the ZEB family and signals from pathways like TGF-β, Wnt, Notch, and PI3K/Akt seem to push cells in this direction. MicroRNAs add small but critical nudges that can either hold the process back or move it further along. But EMT rarely happens as a one-way switch. Ovarian cancer cells often sit somewhere between the two ends of the spectrum, switching identities when needed. This fluid behavior, sometimes called epithelial-mesenchymal plasticity, might help explain why tumors become more diverse, more stem-like, and harder to eliminate. Conditions around the tumor also play a role. Hypoxic pockets, a stiff extracellular matrix, and inflammatory signals not only surround the cancer but may also encourage EMT and help maintain drug-tolerant cells. It's still unclear which of these influences is most decisive, and that uncertainty leaves room for debate. Targeting EMT directly is an appealing idea, and a few strategies are being tested. Whether reversing EMT or stabilizing epithelial features will make standard therapies more effective is not yet settled, but the possibility is driving new interest in combination approaches for ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Health Sciences, Abu Dhabi University, United Arab Emirates; Cancer Research Institute, Office of Research and Sponsored Programs, Abu Dhabi University, United Arab Emirates…
- Department of Chemistry, College of Science (COS), United Arab Emirates University (UAEU), P.O. Box 15551, Al Ain, United Arab Emirates. Electronic address: sadafkhursheed@uaeu.ac.ae.
- National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, Doha, Qatar. Electronic address: dinamoustafa@o6u.edu.eg.
- Department of Chemistry, College of Science (COS), United Arab Emirates University (UAEU), P.O. Box 15551, Al Ain, United Arab Emirates; Zayed bin Sultan Centre for Health Sciences, United Arab Emirates University, P.O.…
- Department of Biomedical Sciences, College of Health Sciences, Abu Dhabi University, United Arab Emirates. Electronic address: asiya.nazir@adu.ac.ae.
Förderung
- Abu Dhabi University
Zitieren
APA
Raza, A., Baba, S. K., El-Ella, D. M. A., Mirza, S., & Nazir, A. (2026). Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer. Pathology - Research and Practice, 280, 156398. https://doi.org/10.1016/j.prp.2026.156398
Vancouver
Raza A, Baba SK, El-Ella DMA, Mirza S, Nazir A. Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer. Pathology - Research and Practice. 2026;280:156398. doi:10.1016/j.prp.2026.156398
BibTeX
@article{Raza2026,
author = {Raza, Afsheen and Baba, Sadaf Khursheed and El-Ella, Dina Moustafa Abo and Mirza, Sameer and Nazir, Asiya},
title = {Epithelial-mesenchymal transition (EMT) and cellular plasticity in Ovarian cancer},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {280},
pages = {156398},
doi = {10.1016/j.prp.2026.156398}
}
EUVIMED